Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
Silver Spring, Maryland, United States
Robert Ball MD, MPH, ScM is Deputy Director, Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research (CDER), FDA. Dr. Ball shares in the responsibilities for leading OSE staff evaluating drug and biologic product safety and effectiveness using Real World Evidence, including managing the Sentinel System.
US Patent author (Ownership Interest includes stock, stock options, patent or other intellectual property, Robert Ball is an author on US Patent 9,075,796, “Text mining for large medical text datasets and corresponding medical text classification using informative feature selection.” At present this patent does not generate royalties.)
WS-10 - New Frontiers in Computable Phenotyping for Medical Product Safety Evaluation
Tuesday, August 24, 2021
11:45 AM – 1:15 PM US Eastern Time
Wednesday, August 25, 2021
11:45 AM – 1:30 PM US Eastern Time